Glaukos announced positive results from a trial evaluating the safety of the surgical exchange procedure for its iDose TR (travoprost...
Read moreDetailsThe landmark LiGHT (Laser in Glaucoma and Ocular Hypertension Trial) study – that ultimately recommended selective laser trabeculoplasty (SLT) as...
Read moreDetailsAncestry may be a factor in the effectiveness of low-dose atropine eye drops for myopia control, according to an Australian-first...
Read moreDetailsThe drug company that produces Eylea (2 mg aflibercept) has announced clinical trial results showing the anti-VEGF therapy can be...
Read moreDetailsA pioneering study out of Western Australia has shown that a longer acting intravitreal dexamethasone implant (DEX-implant) may lead to...
Read moreDetails
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited